Michel T, Häberle H, Pham D T
Klinik für Augenheilkunde, Vivantes Klinikum Neukölln, Berlin.
Klin Monbl Augenheilkd. 2015 May;232(5):676-81. doi: 10.1055/s-0034-1383225. Epub 2014 Nov 13.
The frequency of intravitreal injection of drugs (IVI) has significantly increased recently and it is performed like cataract surgery as an outpatient procedure. The occurrence of postoperative endophthalmitis is rare, only few data of multicentre studies are available.
We analysed the data of 30 consecutive patients with endophthalmitis following cataract surgery (group 1, n = 20) and IVI (group 2, n = 10) requiring therapy in a referral eye clinic from January 2009 to December 2013. All patients received topical and systemic anti-inflammatory and anti-infective therapy. Due to vitreous opacification and severe loss of vision 83 % of the eyes underwent immediately pars plana vitrectomy with diagnostic microbiological probe and intravitreal application of vancomycin and gentamicin.
Endophthalmitis occurred independently in both groups 1 to 10 days, on average 4 days, postoperatively. Group 1 showed conjunctival infection in 80 % (n = 16), group 2 in 20 % (n = 2). Hypopyon was found in group 1 in 65 % (n = 13), in group 2 in 40 % (n = 4). Group 1 presented retinal haemorrhages and epiretinal fibrin membranes in 15 % (n = 3), group 2 in 70 % (n = 7). Vitreous cultures were positive in 80 % (vancomycin-sensitive staphylococci). Staphylococcus was the most frequent bacteria, resistant to ceftazidime. In group 1 visual acuity was initially in 65 % (n = 13) of the eyes < 20/400 or worse, in group 2 90 % (n = 9) of the eyes had hand motions and in 10 % (n = 1) worse than 20/400. Visual outcome was 20/30 on average for group 1, PVR retinal detachment occurred once. In group 2 no patient achieved better visual outcome than < 20/400, 40 % of the eyes required permanent silicon oil tamponade because of PVR retinal detachment. The major pathogens were staphylococci resistant to ceftazidim.
Endophthalmitis following IVI had poor visual outcome compared to endophthalmitis following cataract surgery and showed less anterior segment symptoms.
玻璃体内注射药物(IVI)的频率近来显著增加,并且该操作作为门诊手术,其执行方式类似于白内障手术。术后眼内炎的发生率很低,仅有少量多中心研究的数据。
我们分析了2009年1月至2013年12月间在一家转诊眼科诊所接受治疗的30例白内障手术后发生眼内炎的连续患者(第1组,n = 20)和玻璃体内注射药物后发生眼内炎的患者(第2组,n = 10)的数据。所有患者均接受局部和全身抗炎及抗感染治疗。由于玻璃体混浊和严重视力丧失,83%的患眼立即接受了经平坦部玻璃体切除术,并进行了诊断性微生物检测以及玻璃体内注射万古霉素和庆大霉素。
两组术后1至10天均独立发生眼内炎,平均为术后4天。第1组80%(n = 16)出现结膜感染,第2组为20%(n = 2)。第1组65%(n = 13)发现前房积脓,第2组为40%(n = 4)。第1组15%(n = 3)出现视网膜出血和视网膜前纤维蛋白膜,第2组为70%(n = 7)。玻璃体培养80%呈阳性(对万古霉素敏感的葡萄球菌)。葡萄球菌是最常见的细菌,对头孢他啶耐药。第1组65%(n = 13)患眼的初始视力<20/400或更差,第2组90%(n = 9)患眼仅存手动视力,10%(n = 1)患眼视力比20/400更差。第1组的平均视力结果为20/30,发生了1次增殖性玻璃体视网膜病变(PVR)性视网膜脱离。第2组没有患者的视力结果优于<20/400,40%的患眼因PVR性视网膜脱离需要永久性硅油填塞。主要病原体是对头孢他啶耐药的葡萄球菌。
与白内障手术后的眼内炎相比,玻璃体内注射药物后的眼内炎视力预后较差,且眼前节症状较少。